Lectures

Digital Psychedelia: Hidden Experience and the Challenge of Paranoia

This article is part of the series:

Introduction

Over the past 15 years, several groups of researchers have sought to use clinical trials to reintroduce psychedelics to mainstream society, reporting impressive efficacy from trials at university sites such as Johns Hopkins, New York University and Imperial College London, in the treatment of clinical targets such as unipolar depression and anxiety, addiction and post-traumatic stress disorder (PTSD) …

Lectures

Chronic Experimentation

This article is part of the series:

The introduction of effective combination antiretroviral therapy for HIV disease in 1996 was commonly narrated as a major event that transformed HIV from an inevitable death sentence into a ‘chronic manageable illness’ – at least for those populations in wealthier countries granted socially and economically affordable access to the new treatments, not to mention the relevant clinical infrastructures to monitor …

Lectures

Populist Pharmakons

This article is part of the series:

On March 22, Venezuelan President Nicolás Maduro delivered a long cadena– an impromptu speech carried live by public and regime-controlled TV stations – dedicated exclusively to COVID-19. Wearing, somewhat incongruously, a FC Barcelona tracksuit, Maduro gave a grim report on the spread of the virus around the world and justified his decision to impose a “voluntary and radical national …

Lectures

We urgently need to understand the medication histories of COVID-19 victims

This article is part of the series:

On March 18, 2020, Dr. Anthony Fauci and Dr. Howard Bauchner discussed a possible link between common hypertension medications and a heightened risk of dying with a coronavirus infection. Dr. Fauci directs the National Institute of Allergy and Infectious Diseases and is a key advisor on the White House Coronavirus Task Force. Dr. Bauchner is the Editor of JAMA, …

Features

The Mercurial Life of Drugs: Psychedelics as models, risk factors, and treatments for mental disorders

A Workshop Report by the Neuroscience and Society Network

 

Introduction

The Neuroscience and Society Network organised a workshop on 11-12 July 2018 at the Institute of Psychology, Psychiatry and Neuroscience (IoPPN) at King’s College London (KCL) titled “The Mercurial Life Of Drugs: Psychedelics As Models, Risk Factors, And Treatments For Mental Disorders”. In the workshop, we explored what makes psychedelic …

Features

Sun of the Sleepless

The sleep experiment, back in Chicago in 1992… was that really more than 25 years ago?

In that experiment he could locate the seed of what would become of him—and millions of others. It was a study of night shift work, when it could still be called that. Maximizing labor efficiency by regulating bodies. Today, it seems as if the …